Seek Returns logo

HLN vs. IQV: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at HLN and IQV, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

HLN trades as an American Depositary Receipt (ADR), offering U.S. investors a convenient way to access its foreign-listed shares. In contrast, IQV is a standard domestic listing.

SymbolHLNIQV
Company NameHaleon plcIQVIA Holdings Inc.
CountryUnited KingdomUnited States
GICS SectorConsumer StaplesHealth Care
GICS IndustryPersonal Care ProductsLife Sciences Tools & Services
Market Capitalization43.48 billion USD32.34 billion USD
ExchangeNYSENYSE
Listing DateJuly 25, 2022May 9, 2013
Security TypeADRCommon Stock

Historical Performance

This chart compares the performance of HLN and IQV by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

HLN vs. IQV: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolHLNIQV
5-Day Price Return1.98%6.30%
13-Week Price Return-10.35%21.84%
26-Week Price Return-6.08%-9.40%
52-Week Price Return-5.03%-17.81%
Month-to-Date Return-1.25%2.35%
Year-to-Date Return-5.94%-3.20%
10-Day Avg. Volume18.28M1.49M
3-Month Avg. Volume18.67M2.36M
3-Month Volatility16.25%48.78%
Beta0.351.34

Profitability

Return on Equity (TTM)

HLN

3.26%

Personal Care Products Industry

Max
31.59%
Q3
20.42%
Median
11.01%
Q1
3.26%
Min
-18.42%

HLN’s Return on Equity of 3.26% is on par with the norm for the Personal Care Products industry, indicating its profitability relative to shareholder equity is typical for the sector.

IQV

19.96%

Life Sciences Tools & Services Industry

Max
19.96%
Q3
11.55%
Median
6.22%
Q1
3.86%
Min
-6.95%

In the upper quartile for the Life Sciences Tools & Services industry, IQV’s Return on Equity of 19.96% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.

HLN vs. IQV: A comparison of their Return on Equity (TTM) against their respective Personal Care Products and Life Sciences Tools & Services industry benchmarks.

Net Profit Margin (TTM)

HLN

12.84%

Personal Care Products Industry

Max
15.12%
Q3
12.06%
Median
9.26%
Q1
5.50%
Min
-0.40%

A Net Profit Margin of 12.84% places HLN in the upper quartile for the Personal Care Products industry, signifying strong profitability and more effective cost management than most of its peers.

IQV

7.88%

Life Sciences Tools & Services Industry

Max
27.28%
Q3
16.17%
Median
7.24%
Q1
3.00%
Min
-3.05%

IQV’s Net Profit Margin of 7.88% is aligned with the median group of its peers in the Life Sciences Tools & Services industry. This indicates its ability to convert revenue into profit is typical for the sector.

HLN vs. IQV: A comparison of their Net Profit Margin (TTM) against their respective Personal Care Products and Life Sciences Tools & Services industry benchmarks.

Operating Profit Margin (TTM)

HLN

19.64%

Personal Care Products Industry

Max
19.80%
Q3
17.96%
Median
13.14%
Q1
7.58%
Min
-4.25%

An Operating Profit Margin of 19.64% places HLN in the upper quartile for the Personal Care Products industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

IQV

13.85%

Life Sciences Tools & Services Industry

Max
33.15%
Q3
19.34%
Median
13.02%
Q1
8.05%
Min
-4.38%

IQV’s Operating Profit Margin of 13.85% is around the midpoint for the Life Sciences Tools & Services industry, indicating that its efficiency in managing core business operations is typical for the sector.

HLN vs. IQV: A comparison of their Operating Profit Margin (TTM) against their respective Personal Care Products and Life Sciences Tools & Services industry benchmarks.

Profitability at a Glance

SymbolHLNIQV
Return on Equity (TTM)3.26%19.96%
Return on Assets (TTM)1.58%4.50%
Net Profit Margin (TTM)12.84%7.88%
Operating Profit Margin (TTM)19.64%13.85%
Gross Profit Margin (TTM)60.75%34.25%

Financial Strength

Current Ratio (MRQ)

HLN

0.87

Personal Care Products Industry

Max
4.26
Q3
2.61
Median
1.74
Q1
1.13
Min
0.76

HLN’s Current Ratio of 0.87 falls into the lower quartile for the Personal Care Products industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.

IQV

0.84

Life Sciences Tools & Services Industry

Max
4.76
Q3
2.77
Median
1.85
Q1
1.40
Min
0.43

IQV’s Current Ratio of 0.84 falls into the lower quartile for the Life Sciences Tools & Services industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.

HLN vs. IQV: A comparison of their Current Ratio (MRQ) against their respective Personal Care Products and Life Sciences Tools & Services industry benchmarks.

Debt-to-Equity Ratio (MRQ)

HLN

0.53

Personal Care Products Industry

Max
1.13
Q3
0.63
Median
0.26
Q1
0.04
Min
0.00

HLN’s Debt-to-Equity Ratio of 0.53 is typical for the Personal Care Products industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.

IQV

2.68

Life Sciences Tools & Services Industry

Max
1.75
Q3
0.83
Median
0.41
Q1
0.18
Min
0.00

With a Debt-to-Equity Ratio of 2.68, IQV operates with exceptionally high leverage compared to the Life Sciences Tools & Services industry norm. This suggests an aggressive reliance on debt financing, which can magnify returns but also significantly elevates financial risk.

HLN vs. IQV: A comparison of their Debt-to-Equity Ratio (MRQ) against their respective Personal Care Products and Life Sciences Tools & Services industry benchmarks.

Interest Coverage Ratio (TTM)

HLN

8.00

Personal Care Products Industry

Max
96.53
Q3
59.91
Median
22.25
Q1
7.85
Min
-1.93

HLN’s Interest Coverage Ratio of 8.00 is positioned comfortably within the norm for the Personal Care Products industry, indicating a standard and healthy capacity to cover its interest payments.

IQV

3.68

Life Sciences Tools & Services Industry

Max
29.61
Q3
23.24
Median
6.07
Q1
2.18
Min
-14.08

IQV’s Interest Coverage Ratio of 3.68 is positioned comfortably within the norm for the Life Sciences Tools & Services industry, indicating a standard and healthy capacity to cover its interest payments.

HLN vs. IQV: A comparison of their Interest Coverage Ratio (TTM) against their respective Personal Care Products and Life Sciences Tools & Services industry benchmarks.

Financial Strength at a Glance

SymbolHLNIQV
Current Ratio (MRQ)0.870.84
Quick Ratio (MRQ)0.630.81
Debt-to-Equity Ratio (MRQ)0.532.68
Interest Coverage Ratio (TTM)8.003.68

Growth

Revenue Growth

HLN vs. IQV: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

HLN vs. IQV: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

HLN

0.72%

Personal Care Products Industry

Max
4.08%
Q3
2.46%
Median
1.82%
Q1
0.83%
Min
0.00%

HLN’s Dividend Yield of 0.72% is in the lower quartile for the Personal Care Products industry. This suggests the company’s strategy likely favors retaining earnings for growth over providing a high dividend income.

IQV

0.00%

Life Sciences Tools & Services Industry

Max
1.80%
Q3
0.78%
Median
0.37%
Q1
0.00%
Min
0.00%

IQV currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

HLN vs. IQV: A comparison of their Dividend Yield (TTM) against their respective Personal Care Products and Life Sciences Tools & Services industry benchmarks.

Dividend Payout Ratio (TTM)

HLN

954.40%

Personal Care Products Industry

Max
207.61%
Q3
115.17%
Median
69.37%
Q1
47.71%
Min
0.00%

At 954.40%, HLN’s Dividend Payout Ratio is exceptionally high, exceeding the typical range for the Personal Care Products industry. While this provides a significant return to shareholders, it may limit funds for reinvestment and could be difficult to sustain.

IQV

0.00%

Life Sciences Tools & Services Industry

Max
156.00%
Q3
65.73%
Median
23.81%
Q1
0.00%
Min
0.00%

IQV has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

HLN vs. IQV: A comparison of their Dividend Payout Ratio (TTM) against their respective Personal Care Products and Life Sciences Tools & Services industry benchmarks.

Dividend at a Glance

SymbolHLNIQV
Dividend Yield (TTM)0.72%0.00%
Dividend Payout Ratio (TTM)954.40%0.00%

Valuation

Price-to-Earnings Ratio (TTM)

HLN

22.09

Personal Care Products Industry

Max
55.49
Q3
36.75
Median
26.49
Q1
22.40
Min
11.12

In the lower quartile for the Personal Care Products industry, HLN’s P/E Ratio of 22.09 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.

IQV

25.98

Life Sciences Tools & Services Industry

Max
117.96
Q3
65.59
Median
37.26
Q1
27.51
Min
1.73

In the lower quartile for the Life Sciences Tools & Services industry, IQV’s P/E Ratio of 25.98 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.

HLN vs. IQV: A comparison of their Price-to-Earnings Ratio (TTM) against their respective Personal Care Products and Life Sciences Tools & Services industry benchmarks.

Price-to-Sales Ratio (TTM)

HLN

2.84

Personal Care Products Industry

Max
5.35
Q3
2.83
Median
2.07
Q1
1.13
Min
0.00

HLN’s P/S Ratio of 2.84 is in the upper echelon for the Personal Care Products industry. This means the company is valued richly on its revenue stream compared to its peers, suggesting the stock is priced for a high level of future performance.

IQV

2.05

Life Sciences Tools & Services Industry

Max
12.46
Q3
6.70
Median
4.24
Q1
2.68
Min
0.73

In the lower quartile for the Life Sciences Tools & Services industry, IQV’s P/S Ratio of 2.05 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.

HLN vs. IQV: A comparison of their Price-to-Sales Ratio (TTM) against their respective Personal Care Products and Life Sciences Tools & Services industry benchmarks.

Price-to-Book Ratio (MRQ)

HLN

2.11

Personal Care Products Industry

Max
7.32
Q3
5.26
Median
2.93
Q1
1.84
Min
1.14

HLN’s P/B Ratio of 2.11 is within the conventional range for the Personal Care Products industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.

IQV

4.72

Life Sciences Tools & Services Industry

Max
7.99
Q3
4.69
Median
3.30
Q1
1.88
Min
1.02

IQV’s P/B Ratio of 4.72 is in the upper tier for the Life Sciences Tools & Services industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.

HLN vs. IQV: A comparison of their Price-to-Book Ratio (MRQ) against their respective Personal Care Products and Life Sciences Tools & Services industry benchmarks.

Valuation at a Glance

SymbolHLNIQV
Price-to-Earnings Ratio (TTM)22.0925.98
Price-to-Sales Ratio (TTM)2.842.05
Price-to-Book Ratio (MRQ)2.114.72
Price-to-Free Cash Flow Ratio (TTM)14.8115.99